Patients treated with oxaliplatin are at risk for thrombocytopenia caused by multiple drug-dependent antibodies

Brian R. Curtis; Yen Michael S. Hsu; Nikolai Podoltsev; Jill Lacy; Susanna Curtis; Michael S. Samuel; Kristin Zutavern; Robert A. DeSimone; Daniel W. Bougie; Richard H. Aster

doi:10.1182/blood-2017-10-812461

Patients treated with oxaliplatin are at risk for thrombocytopenia caused by multiple drug-dependent antibodies

Brian R. Curtis, Yen Michael S. Hsu, Nikolai Podoltsev, Jill Lacy, Susanna Curtis, Michael S. Samuel, Kristin Zutavern, Robert A. DeSimone, Daniel W. Bougie, Richard H. Aster

Research output: Contribution to journal › Letter › peer-review

14 Scopus citations

Original language	English (US)
Pages (from-to)	1489
Number of pages	1
Journal	Blood
Volume	131
Issue number	13
DOIs	https://doi.org/10.1182/blood-2017-10-812461
State	Published - Mar 29 2018
Externally published	Yes

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2017-10-812461

Cite this

@article{f350fe2a66814d53851d00a41c4d82a9,

title = "Patients treated with oxaliplatin are at risk for thrombocytopenia caused by multiple drug-dependent antibodies",

author = "Curtis, {Brian R.} and Hsu, {Yen Michael S.} and Nikolai Podoltsev and Jill Lacy and Susanna Curtis and Samuel, {Michael S.} and Kristin Zutavern and DeSimone, {Robert A.} and Bougie, {Daniel W.} and Aster, {Richard H.}",

note = "Funding Information: This work was supported by a grant from the Stiftung H{\"a}motherapie-Forschung (Hemotherapy Research Foundation). Funding Information: This work was supported by grant HL-13629 from the National Heart, Lung, and Blood Institute, National Institutes of Health.",

year = "2018",

month = mar,

day = "29",

doi = "10.1182/blood-2017-10-812461",

language = "English (US)",

volume = "131",

pages = "1489",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "13",

}

TY - JOUR

T1 - Patients treated with oxaliplatin are at risk for thrombocytopenia caused by multiple drug-dependent antibodies

AU - Curtis, Brian R.

AU - Hsu, Yen Michael S.

AU - Podoltsev, Nikolai

AU - Lacy, Jill

AU - Curtis, Susanna

AU - Samuel, Michael S.

AU - Zutavern, Kristin

AU - DeSimone, Robert A.

AU - Bougie, Daniel W.

AU - Aster, Richard H.

N1 - Funding Information: This work was supported by a grant from the Stiftung Hämotherapie-Forschung (Hemotherapy Research Foundation). Funding Information: This work was supported by grant HL-13629 from the National Heart, Lung, and Blood Institute, National Institutes of Health.

PY - 2018/3/29

Y1 - 2018/3/29

UR - http://www.scopus.com/inward/record.url?scp=85047628793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047628793&partnerID=8YFLogxK

U2 - 10.1182/blood-2017-10-812461

DO - 10.1182/blood-2017-10-812461

M3 - Letter

C2 - 29439950

AN - SCOPUS:85047628793

SN - 0006-4971

VL - 131

SP - 1489

JO - Blood

JF - Blood

IS - 13

ER -

Patients treated with oxaliplatin are at risk for thrombocytopenia caused by multiple drug-dependent antibodies

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this